Strategies for reducing intestinal atrophy during total parenteral nutrition: role of intravenous nucleosides and nucleotides.
Shenkin
A
A
Department of Clinical Chemistry, University of Liverpool, UK.
D000818:Animals; D001284:Atrophy; D001363:Awards and Prizes; D006801:Humans; D007410:Intestinal Diseases / Q000209:etiology / Q000517:prevention & control*; D007413:Intestinal Mucosa / Q000473:pathology*; D009705:Nucleosides / Q000008:administration & dosage / Q000627:therapeutic use*; D009711:Nucleotides / Q000008:administration & dosage / Q000627:therapeutic use*; D009747:Nutritional Physiological Phenomena; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*; D051381:Rats
D009705:Nucleosides; D009711:Nucleotides